Literature DB >> 15994370

Vascular binding, blood flow, transporter, and enzyme interactions on the processing of digoxin in rat liver.

Lichuan Liu1, Ernie Mak, Rommel G Tirona, Eugene Tan, Phyllis M Novikoff, Pijun Wang, Allan W Wolkoff, K Sandy Pang.   

Abstract

The roles of vascular binding, flow, transporters, and enzymes as determinants of the clearance of digoxin were examined in the rat liver. Digoxin is metabolized by Cyp3a and utilizes the organic anion transporting polypeptide 2 (Oatp2) and P-glycoprotein (Pgp) for influx and excretion, respectively. Uptake of digoxin was found to be similar among rat periportal (PP) and perivenous (PV) hepatocytes isolated by the digitonin-collagenase method. The Km values for uptake were 180 +/- 112 and 390 +/- 406 nM, Vmax values were 13 +/- 8 and 18 +/- 4.9 pmol/min/mg protein, and nonsaturable components were 9.2 +/- 1.3 and 10.7 +/- 2.5 microl/min/mg for PP and PV, respectively. The evenness of distribution of Oatp2 and Pgp was confirmed by Western blotting and confocal immunofluorescent microscopy. When digoxin was recirculated to the rat liver preparation in Krebs-Henseleit bicarbonate (KHB) for 3 h in absence or presence of 1% bovine serum albumin (BSA) and 20% red blood cell (rbc) at flow rates of 40 and 10 ml/min, respectively, biexponential decays were observed. Fitted results based on compartmental analyses revealed a higher clearance (0.244 +/- 0.082 ml/min/g) for KHB-perfused livers over the rbc-albumin-perfused livers (0.114 +/- 0.057 ml/min/g) (P < 0.05). We further found that binding of digoxin to 1% BSA was modest (unbound fraction = 0.64), whereas binding to rbc was associated with slow on (0.468 +/- 0.021 min(-1)) and off (1.81 +/- 0.12 min(-1)) rate constants. We then used a zonal, physiologically based pharmacokinetic model to show that the difference in digoxin clearance was attributed to binding to BSA and rbc and not to the difference in flow rate and that clearance was unaffected by transporter or enzyme heterogeneity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994370     DOI: 10.1124/jpet.105.088039

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  An improved nonlinear model describing the hepatic pharmacokinetics of digoxin: evidence for two functionally different uptake systems and saturable binding.

Authors:  Michael Weiss; Peng Li; Michael S Roberts
Journal:  Pharm Res       Date:  2010-07-13       Impact factor: 4.200

Review 2.  Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts.

Authors:  K Sandy Pang; Michael Weiss; Panos Macheras
Journal:  AAPS J       Date:  2007-06-29       Impact factor: 4.009

3.  Vitamin D receptor activation induces P-glycoprotein and increases brain efflux of quinidine: an intracerebral microdialysis study in conscious rats.

Authors:  Matthew R Durk; Jianghong Fan; Huadong Sun; Yingbo Yang; Henrianna Pang; K Sandy Pang; Inés A M de Lannoy
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

4.  Rat Organic Anion Transport Protein 1A1 Interacts Directly With Organic Anion Transport Protein 1A4 Facilitating Its Maturation and Trafficking to the Hepatocyte Plasma Membrane.

Authors:  Pijun Wang; Wen-Jun Wang; Jo Choi-Nurvitadhi; Yaniuska Lescaille; John W Murray; Allan W Wolkoff
Journal:  Hepatology       Date:  2019-06-26       Impact factor: 17.425

Review 5.  Organic anion uptake by hepatocytes.

Authors:  Allan W Wolkoff
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

Review 6.  Liver tissue engineering in the evaluation of drug safety.

Authors:  Ajit Dash; Walker Inman; Keith Hoffmaster; Samantha Sevidal; Joan Kelly; R Scott Obach; Linda G Griffith; Steven R Tannenbaum
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-10       Impact factor: 4.481

7.  Effect of albumin on the biliary clearance of compounds in sandwich-cultured rat hepatocytes.

Authors:  Kristina K Wolf; Kenneth R Brouwer; Gary M Pollack; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2008-07-24       Impact factor: 3.922

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.